Clinical Trials Browser

Recruiting × ulixertinib × Clear all

NCT05985954 2026-03-12

Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy

Phase 1 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05804227 2026-02-27

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

Phase EARLY_PHASE1 Recruiting

Glioma

NCT06411821 2025-12-15

Ulixertinib in People With Histiocytic Neoplasms

Phase 2 Recruiting

Histiocytic Neoplasms

NCT03454035 2025-09-11

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Phase 1 Recruiting

DermatologicGastrointestinal

Melanoma, Neoplasms, Pancreatic Neoplasms